MedTrace Logo

Quality of Life With Nutritional Supplementation in Patients With Locally Advanced/Metastatic Pancreatic Cancer.

NCT05360745 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2026-02-11

No results posted yet for this study

Summary

Metastatic pancreatic cancer has a poor prognosis, with approximately one-third of patients experiencing poor quality of life at six months.

ARACOMPLEX® is a food supplement that contains maca extract, vitamin complexes and ions, and this nutritional contribution seems to favor the improvement of the patient's quality of life. To verify this statement, this experimental study is carried out in patients with locally advanced/metastatic pancreatic cancer.

Conditions

Interventions

DIETARY_SUPPLEMENT

ARACOMPLEX®

ARACOMPLEX® is an authorized food supplement that contains maca extract, vitamin complexes and ions, and that improves the quality of life of the patient.

DIETARY_SUPPLEMENT

placebo

Placebo has a composition that makes its weight and organoleptic characteristics are identical to ARACOMPLEX®.

Sponsors & Collaborators

  • Fundacion para la Excelencia y la Calidad de la Oncologia

    lead OTHER

Principal Investigators

  • Sergio Sandiego, Doctor · Fundación Instituto Valenciano de Oncología

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-29
Primary Completion
2023-09-12
Completion
2023-09-12

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05360745 on ClinicalTrials.gov